Catherine Emmanuel

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. pmc Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis
    Catherine Emmanuel
    Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia
    PLoS ONE 6:e17617. 2011
  2. doi Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver
    Catherine Emmanuel
    Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia
    Clin Cancer Res 20:6618-30. 2014
  3. pmc MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
    Jennifer A Byrne
    Molecular Oncology Laboratory, Children s Cancer Research Unit, The Children s Hospital at Westmead, Westmead, New South Wales, Australia
    BMC Cancer 10:497. 2010

Detail Information

Publications3

  1. pmc Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis
    Catherine Emmanuel
    Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia
    PLoS ONE 6:e17617. 2011
    ....
  2. doi Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver
    Catherine Emmanuel
    Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia
    Clin Cancer Res 20:6618-30. 2014
    ..We sought to determine whether borderline histology associated with grade 2 or 3 carcinoma was an indicator of Ras mutation, and we explored the molecular relationship between coexisting invasive and borderline histologies...
  3. pmc MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
    Jennifer A Byrne
    Molecular Oncology Laboratory, Children s Cancer Research Unit, The Children s Hospital at Westmead, Westmead, New South Wales, Australia
    BMC Cancer 10:497. 2010
    ..MAL2 binds tumor protein D52 (TPD52), which is frequently overexpressed in ovarian carcinoma, but the clinical significance of MAL2 and TPD52 overexpression was unknown...